REGENIFIED LTD. – Trademark Portfolio

Entity Type: 03

REGENIFIED LTD. owns a portfolio of 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as R, REGENIFIED, and CERTIFIED REGENIFIED REGENIFIED.COM R. Of these, 3 are registered and 2 are pending. The portfolio spans 2 Nice Classification classes, led by Class 35 (Advertising & Business) and Class 41 (Education & Entertainment). Headquartered in Dallas, TX.

2825 Oak Lawn Avenue

Dallas, TX 75219

6 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

REGENIFIED LTD.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (1 filing)

Advertising; business management; business administration; office functions

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

Frequently Asked Questions

How many trademarks does REGENIFIED LTD. have?

REGENIFIED LTD. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending, 1 abandoned.

What trademark classes does REGENIFIED LTD. file in?

REGENIFIED LTD. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 41 (Education & Entertainment). Class 35 covers advertising; business management; business administration; office functions.

What are REGENIFIED LTD.'s most well-known trademarks?

REGENIFIED LTD.'s registered trademark portfolio includes well-known marks such as R, REGENIFIED, and CERTIFIED REGENIFIED REGENIFIED.COM R. These are among 3 currently registered trademarks in the portfolio.

What is REGENIFIED LTD.'s trademark registration success rate?

REGENIFIED LTD. has a 75% trademark registration rate, with 3 out of 4 resolved applications resulting in successful registration. Currently, 2 applications are pending review.